Coronary collateral circulation in patients of coronary ectasia with significant coronary artery disease

Po-Chao Hsu1, Ho-Ming Su2, Hsiang-Chun Lee3

  • 1Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan ; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan ; Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Plos One
|January 30, 2014
PubMed

Insights

Coronary ectasia (CE) is linked to poorer coronary collateral development in patients with significant coronary artery disease (SCAD). This finding highlights the importance of assessing CE in SCAD patients for better cardiovascular event prediction.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Coronary ectasia (CE) often coexists with coronary stenosis, leading to myocardial ischemia.
  • Coronary collaterals are crucial for protecting the myocardium from ischemia and reducing cardiovascular events.
  • The role of CE in the development of coronary collaterals remains understudied.

Purpose of the Study:

  • To investigate the association between coronary ectasia (CE) and coronary collateral development in patients with significant coronary artery disease (SCAD).

Main Methods:

  • Evaluated 1020 patients undergoing coronary angiography; 552 with SCAD (diameter stenosis >70%) were analyzed.
  • Defined CE as an ectatic diameter 1.5 times larger than the adjacent reference segment.
  • Classified coronary collateral function using the Rentrop score (poor: grades 0-1; good: grades 2-3).

Main Results:

  • CE lesions were present in 13.2% of patients, predominantly in the right coronary artery.
  • Patients with CE exhibited poorer coronary collateral function (58.2% vs 71.2%, p=0.040).
  • Multivariate analysis identified CE (OR=0.544, p=0.048) as a significant predictor of poorer coronary collateral development.

Conclusions:

  • The presence of coronary ectasia is associated with impaired coronary collateral development in patients with significant coronary artery disease.
  • This association suggests CE may negatively impact myocardial protection in SCAD patients.
  • Further research is warranted to explore the clinical implications of this finding.
Abstract

Related Concept Videos

Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
9.9K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K